Cell reports. Medicine · 2022
Mature neutrophils and a NF-κB-to-IFN transition determine the unifying disease recovery dynamics in COVID-19.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Frishberg Amit, Kooistra Emma, Nuesch-Germano Melanie, Pecht Tal, Milman Neta, Reusch Nico, Warnat-Herresthal Stefanie, Bruse Niklas, Händler Kristian, Theis Heidi, Kraut Michael, van Rijssen Esther, van Cranenbroek Bram, Koenen Hans Jpm, Heesakkers Hidde, van den Boogaard Mark, Zegers Marieke, Pickkers Peter, Becker Matthias, Aschenbrenner Anna C, Ulas Thomas, Theis Fabian J, Shen-Orr Shai S, Schultze Joachim L, Kox Matthijs
Аннотация
Disease recovery dynamics are often difficult to assess, as patients display heterogeneous recovery courses. To model recovery dynamics, exemplified by severe COVID-19, we apply a computational scheme on longitudinally sampled blood transcriptomes, generating recovery states, which we then link to cellular and molecular mechanisms, presenting a framework for studying the kinetics of recovery compared with non-recovery over time and long-term effects of the disease. Specifically, a decrease in mature neutrophils is the strongest cellular effect during recovery, with direct implications on disease outcome. Furthermore, we present strong indications for global regulatory changes in gene programs, decoupled from cell compositional changes, including an early rise in T cell activation and differentiation, resulting in immune rebalancing between interferon and NF-κB activity and restoration of cell homeostasis. Overall, we present a clinically relevant computational framework for modeling disease recovery, paving the way for future studies of the recovery dynamics in other diseases and tissues.